Stock Rating Downgrade
In the last week the Value Trend Rating for Vanda Pharmaceuticals Inc (NASDAQ: VNDA) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock enjoyed a large increase of 2.8% on 4/19/24. The stock closed at $5.11. NORMAL trading volume accompanied the advance. Relative to the market the stock has been weak over the last nine months but has risen 19.4% during the last week.
Current PriceTarget Research Rating
VNDA is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Vanda Pharmaceuticals has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Vanda Pharmaceuticals has a slightly positive Appreciation Score of 66 but a poor Power Rating of 21, leading to the Negative Value Trend Rating.
Be the first to comment